Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Gastric Cancer

  Free Subscription

Articles published in BMC Cancer

Retrieve available abstracts of 204 articles:
HTML format

Single Articles

    September 2020
  1. JIN X, Dai L, Ma Y, Wang J, et al
    Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:866.
    PubMed     Abstract available

    August 2020
  2. ZHU L, Xu Z, Wu Y, Liu P, et al
    Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study.
    BMC Cancer. 2020;20:827.
    PubMed     Abstract available

  3. ZHENG Z, Yin J, Li Z, Ye Y, et al
    Protocol for expanded indications of endoscopic submucosal dissection for early gastric cancer in China: a multicenter, ambispective, observational, open-cohort study.
    BMC Cancer. 2020;20:801.
    PubMed     Abstract available

    July 2020
  4. MATSUMOTO T, Yamamoto Y, Kuriona Y, Okazaki U, et al
    Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses.
    BMC Cancer. 2020;20:684.
    PubMed     Abstract available

  5. YANG C, Shi Y, Xie S, Chen J, et al
    Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study.
    BMC Cancer. 2020;20:669.
    PubMed     Abstract available

  6. EBRAHIMI GHAHNAVIEH L, Tabatabaeian H, Ebrahimi Ghahnavieh Z, Honardoost MA, et al
    Fluctuating expression of miR-584 in primary and high-grade gastric cancer.
    BMC Cancer. 2020;20:621.
    PubMed     Abstract available

    June 2020
  7. PENG Z, Guan Q, Luo J, Deng W, et al
    Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated beta-catenin degradation in gastric cancer.
    BMC Cancer. 2020;20:582.
    PubMed     Abstract available

  8. HIRATA K, Hamamoto Y, Ando M, Imamura CK, et al
    Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II
    BMC Cancer. 2020;20:548.
    PubMed     Abstract available

  9. SUN QH, Yin ZX, Li Z, Tian SB, et al
    miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9.
    BMC Cancer. 2020;20:522.
    PubMed     Abstract available

  10. TOYOKAWA T, Muguruma K, Yoshii M, Tamura T, et al
    Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    BMC Cancer. 2020;20:517.
    PubMed     Abstract available

  11. TAVAKOLI A, Monavari SH, Solaymani Mohammadi F, Kiani SJ, et al
    Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:493.
    PubMed     Abstract available

    May 2020
  12. SUN KY, Hu HT, Chen SL, Ye JN, et al
    CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.
    BMC Cancer. 2020;20:468.
    PubMed     Abstract available

  13. KPOGHOMOU MA, Wang J, Wang T, Jin G, et al
    Association of Helicobacter pylori babA2 gene and gastric cancer risk: a meta-analysis.
    BMC Cancer. 2020;20:465.
    PubMed     Abstract available

  14. LI WH, Zhang JY, Liu WH, Chen XX, et al
    Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: a retrospective analysis.
    BMC Cancer. 2020;20:414.
    PubMed     Abstract available

  15. TANG S, Lin L, Cheng J, Zhao J, et al
    The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer.
    BMC Cancer. 2020;20:382.
    PubMed     Abstract available

    April 2020
  16. NAKAMURA N, Kinami S, Tomita Y, Miyata T, et al
    The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study.
    BMC Cancer. 2020;20:363.
    PubMed     Abstract available

  17. KAWAI S, Fukuda N, Yamamoto S, Mitani S, et al
    Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.
    BMC Cancer. 2020;20:338.
    PubMed     Abstract available

  18. YOON SJ, Park J, Shin Y, Choi Y, et al
    Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model.
    BMC Cancer. 2020;20:314.
    PubMed     Abstract available

    March 2020
  19. BEEHARRY MK, Ni ZT, Yang ZY, Zheng YN, et al
    Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gas
    BMC Cancer. 2020;20:224.
    PubMed     Abstract available

  20. WANG M, Li Z, Peng Y, Fang J, et al
    Identification of immune cells and mRNA associated with prognosis of gastric cancer.
    BMC Cancer. 2020;20:206.
    PubMed     Abstract available

  21. KONO Y, Saito H, Miyauchi W, Shimizu S, et al
    Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients.
    BMC Cancer. 2020;20:175.
    PubMed     Abstract available

  22. CHOI JH, Choi YW, Kang SY, Jeong GS, et al
    Combination versus single-agent as palliative chemotherapy for gastric cancer.
    BMC Cancer. 2020;20:167.
    PubMed     Abstract available

    February 2020
  23. ZHENG G, Liu J, Guo Y, Wang F, et al
    Necessity of prophylactic splenic hilum lymph node clearance for middle and upper third gastric cancer: a network meta-analysis.
    BMC Cancer. 2020;20:149.
    PubMed     Abstract available

    January 2020
  24. HU X, Zhao F, Yu H, Luo Y, et al
    GC-PROM: validation of a patient-reported outcomes measure for Chinese patients with gastric cancer.
    BMC Cancer. 2020;20:41.
    PubMed     Abstract available

  25. MOORE A, Hikri E, Goshen-Lago T, Barkan T, et al
    Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
    BMC Cancer. 2020;20:34.
    PubMed     Abstract available

  26. LIN JX, Lin JP, Xie JW, Wang JB, et al
    Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
    BMC Cancer. 2020;20:11.
    PubMed     Abstract available

  27. WANG CY, Yang J, Zi H, Zheng ZL, et al
    Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    BMC Cancer. 2020;20:10.
    PubMed     Abstract available

    December 2019
  28. BEEHARRY MK, Zhu ZL, Liu WT, Yao XX, et al
    Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    BMC Cancer. 2019;19:1256.
    PubMed     Abstract available

  29. SHIN K, Park SJ, Lee J, Park CH, et al
    Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    BMC Cancer. 2019;19:1232.
    PubMed     Abstract available

  30. KOSUGA T, Konishi T, Kubota T, Shoda K, et al
    Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer.
    BMC Cancer. 2019;19:1187.
    PubMed     Abstract available

    November 2019
  31. ZHENG HL, Lu J, Xie JW, Wang JB, et al
    Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients.
    BMC Cancer. 2019;19:1127.
    PubMed     Abstract available

  32. GUO X, Zhao F, Ma X, Shen G, et al
    A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:1125.
    PubMed     Abstract available

  33. WANG X, Zhao J, Fairweather M, Yang T, et al
    Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database.
    BMC Cancer. 2019;19:1079.
    PubMed     Abstract available

  34. LIN JX, Wang ZK, Wang W, Desiderio J, et al
    Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.
    BMC Cancer. 2019;19:1048.
    PubMed     Abstract available

    October 2019
  35. LIU P, McMenamin UC, Spence AD, Johnston BT, et al
    Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
    BMC Cancer. 2019;19:1017.
    PubMed     Abstract available

  36. BU X, Zhang A, Chen Z, Zhang X, et al
    Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating alpha7-nicotinic acetylcholine receptors/ERK- EMT.
    BMC Cancer. 2019;19:976.
    PubMed     Abstract available

  37. MASUDA K, Shoji H, Nagashima K, Yamamoto S, et al
    Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
    BMC Cancer. 2019;19:974.
    PubMed     Abstract available

  38. TANIOKA H, Nagasaka T, Uno F, Inoue M, et al
    The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
    BMC Cancer. 2019;19:941.
    PubMed     Abstract available

    September 2019
  39. YOU X, Zhou Q, Song J, Gan L, et al
    Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy.
    BMC Cancer. 2019;19:931.
    PubMed     Abstract available

  40. BEEHARRY MK, Zhu ZL, Liu WT, Yao XX, et al
    Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    BMC Cancer. 2019;19:932.
    PubMed     Abstract available

  41. MESIC A, Rogar M, Hudler P, Bilalovic N, et al
    Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    BMC Cancer. 2019;19:919.
    PubMed     Abstract available

  42. LU J, Xu Y, Wu Y, Huang XY, et al
    Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    BMC Cancer. 2019;19:920.
    PubMed     Abstract available

  43. DING P, Gao Z, Zheng C, Chen J, et al
    Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
    BMC Cancer. 2019;19:905.
    PubMed     Abstract available

  44. YEO ST, Bray N, Haboubi H, Hoare Z, et al
    Endoscopic ultrasound staging in patients with gastro-oesophageal cancers: a systematic review of economic evidence.
    BMC Cancer. 2019;19:900.
    PubMed     Abstract available

  45. LIN JL, Lin JX, Li P, Xie JW, et al
    Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study.
    BMC Cancer. 2019;19:873.
    PubMed     Abstract available

  46. KIM H, Son SM, Woo CG, Lee OJ, et al
    Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions.
    BMC Cancer. 2019;19:834.
    PubMed     Abstract available

    August 2019
  47. MA T, Wu ZJ, Xu H, Wu CH, et al
    Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    BMC Cancer. 2019;19:852.
    PubMed     Abstract available

  48. CHENG Y, Xiao Y, Zhou R, Liao Y, et al
    Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.
    BMC Cancer. 2019;19:842.
    PubMed     Abstract available

  49. YUAN P, Wu Z, Li Z, Bu Z, et al
    Impact of postoperative major complications on long-term survival after radical resection of gastric cancer.
    BMC Cancer. 2019;19:833.
    PubMed     Abstract available

  50. TANG X, He Q, Qu H, Sun G, et al
    Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy.
    BMC Cancer. 2019;19:797.
    PubMed     Abstract available

  51. PAK KH, Park KC, Cheong JH
    VEGF-C induced by TGF- beta1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
    BMC Cancer. 2019;19:799.
    PubMed     Abstract available

  52. LIU G, Hu Y, Cheng X, Wang Y, et al
    Volumetric parameters on (18)F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET.
    BMC Cancer. 2019;19:790.
    PubMed     Abstract available

  53. LIU J, Liu Z, Zhang X, Gong T, et al
    Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    BMC Cancer. 2019;19:759.
    PubMed     Abstract available

    July 2019
  54. MEI JW, Yang ZY, Xiang HG, Bao R, et al
    MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.
    BMC Cancer. 2019;19:740.
    PubMed     Abstract available

  55. JO MJ, Jeong S, Yun HK, Kim DY, et al
    Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.
    BMC Cancer. 2019;19:739.
    PubMed     Abstract available

  56. HIRAHARA T, Arigami T, Yanagita S, Matsushita D, et al
    Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
    BMC Cancer. 2019;19:672.
    PubMed     Abstract available

  57. ARAI H, Iwasa S, Boku N, Kawahira M, et al
    Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
    BMC Cancer. 2019;19:652.
    PubMed     Abstract available

  58. XU J, Zhu R, Fan L, Ge S, et al
    Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.
    BMC Cancer. 2019;19:650.
    PubMed     Abstract available

    June 2019
  59. QI Y, Lv J, Liu S, Sun L, et al
    TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression.
    BMC Cancer. 2019;19:630.
    PubMed     Abstract available

  60. LIU X, Jin J, Cai H, Huang H, et al
    Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    BMC Cancer. 2019;19:606.
    PubMed     Abstract available

  61. DOMINGUEZ RL, Cherry CB, Estevez-Ordonez D, Mera R, et al
    Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.
    BMC Cancer. 2019;19:545.
    PubMed     Abstract available

    May 2019
  62. DONG C, Sun J, Ma S, Zhang G, et al
    K-ras-ERK1/2 down-regulates H2A.X(Y142ph) through WSTF to promote the progress of gastric cancer.
    BMC Cancer. 2019;19:530.
    PubMed     Abstract available

  63. LI Y, Yan X, Shi J, He Y, et al
    Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/beta-catenin signaling.
    BMC Cancer. 2019;19:505.
    PubMed     Abstract available

  64. WAGNER AD, Grabsch HI, Mauer M, Marreaud S, et al
    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction
    BMC Cancer. 2019;19:494.
    PubMed     Abstract available

  65. XIA X, Xu J, Zhu C, Cao H, et al
    Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer.
    BMC Cancer. 2019;19:481.
    PubMed     Abstract available

  66. KIM YJ, Chung WC, Jun KH, Chin HM, et al
    Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy.
    BMC Cancer. 2019;19:483.
    PubMed     Abstract available

  67. WANG F, He MM, Wang ZX, Li S, et al
    Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
    BMC Cancer. 2019;19:460.
    PubMed     Abstract available

  68. LI Q, Xu X, Su D, Zhou T, et al
    Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review.
    BMC Cancer. 2019;19:459.
    PubMed     Abstract available

  69. MARTINEZ-CAMPOS C, Torres-Poveda K, Camorlinga-Ponce M, Flores-Luna L, et al
    Polymorphisms in IL-10 and TGF-beta gene promoter are associated with lower risk to gastric cancer in a Mexican population.
    BMC Cancer. 2019;19:453.
    PubMed     Abstract available

  70. KOEMANS WJ, van der Kaaij RT, Boot H, Buffart T, et al
    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    BMC Cancer. 2019;19:420.
    PubMed     Abstract available

    April 2019
  71. LI C, Wang X, Wang X, Han C, et al
    A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
    BMC Cancer. 2019;19:397.
    PubMed     Abstract available

  72. LI WY, Han Y, Xu HM, Wang ZN, et al
    Smoking status and subsequent gastric cancer risk in men compared with women: a meta-analysis of prospective observational studies.
    BMC Cancer. 2019;19:377.
    PubMed     Abstract available

  73. LV Y, Han X, Xu XF, Ji Y, et al
    Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    BMC Cancer. 2019;19:335.
    PubMed     Abstract available

  74. LI L, Kang D, Huang Z, Zhan Z, et al
    Multimodal multiphoton imaging for label-free monitoring of early gastric cancer.
    BMC Cancer. 2019;19:295.
    PubMed     Abstract available

    March 2019
  75. DI BARTOLOMEO M, Niger M, Morano F, Corallo S, et al
    Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
    BMC Cancer. 2019;19:283.
    PubMed     Abstract available

  76. SUI H, Lou A, Li Z, Yang J, et al
    Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.
    BMC Cancer. 2019;19:233.
    PubMed     Abstract available

  77. LIU J, Liu Z, Zhang X, Gong T, et al
    Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    BMC Cancer. 2019;19:227.
    PubMed     Abstract available

  78. LU J, Dai Y, Xie JW, Wang JB, et al
    Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
    BMC Cancer. 2019;19:216.
    PubMed     Abstract available

  79. DONIDA BM, Tomasello G, Ghidini M, Buffoli F, et al
    Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.
    BMC Cancer. 2019;19:212.
    PubMed     Abstract available

  80. LEE CM, Park JH, In Choi C, Lee HH, et al
    A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).
    BMC Cancer. 2019;19:206.
    PubMed     Abstract available

    February 2019
  81. LIAN L, Li XL, Xu MD, Li XM, et al
    VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
    BMC Cancer. 2019;19:183.
    PubMed     Abstract available

  82. MAO Y, Yang W, Qi Q, Yu F, et al
    Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
    BMC Cancer. 2019;19:164.
    PubMed     Abstract available

  83. KIM TM, Ko YH, Ha SJ, Lee HH, et al
    Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    BMC Cancer. 2019;19:119.
    PubMed     Abstract available

    January 2019
  84. LI Z, Wang Y, Ying X, Shan F, et al
    Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2019;19:80.
    PubMed     Abstract available

  85. BUSTOS-CARPINTEYRO AR, Oliveira C, Sousa A, Oliveira P, et al
    CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    BMC Cancer. 2019;19:69.
    PubMed     Abstract available

  86. BRAGA LLBC, Batista MHR, de Azevedo OGR, da Silva Costa KC, et al
    oipA "on" status of Helicobacter pylori is associated with gastric cancer in North-Eastern Brazil.
    BMC Cancer. 2019;19:48.
    PubMed     Abstract available

  87. ZHANG X, Shen B, Cui Y
    Ago HITS-CLIP expands microRNA-mRNA interactions in nucleus and cytoplasm of gastric cancer cells.
    BMC Cancer. 2019;19:29.
    PubMed     Abstract available

  88. LIN MQ, Wang JB, Zheng CH, Li P, et al
    A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study.
    BMC Cancer. 2019;19:21.
    PubMed     Abstract available

  89. SHI Y, Huang X, Chen G, Wang Y, et al
    miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
    BMC Cancer. 2019;19:14.
    PubMed     Abstract available

    December 2018
  90. ZHANG J, Qiu W, Liu H, Qian C, et al
    Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    BMC Cancer. 2018;18:1270.
    PubMed     Abstract available

  91. MORI M, Shuto K, Kosugi C, Narushima K, et al
    An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
    BMC Cancer. 2018;18:1261.
    PubMed     Abstract available

    November 2018
  92. LI Z, Shan F, Ying X, Xue K, et al
    Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial.
    BMC Cancer. 2018;18:1118.
    PubMed     Abstract available

  93. BEOM SH, Choi YY, Baek SE, Li SX, et al
    Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
    BMC Cancer. 2018;18:1116.
    PubMed     Abstract available

  94. LIU J, Huang C, Peng C, Xu F, et al
    Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ beta-catenin pathway.
    BMC Cancer. 2018;18:1099.
    PubMed     Abstract available

  95. HUANG ZN, Chen QY, Zheng CH, Li P, et al
    Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.
    BMC Cancer. 2018;18:1064.
    PubMed     Abstract available

    October 2018
  96. MAGALHAES L, Quintana LG, Lopes DCF, Vidal AF, et al
    APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
    BMC Cancer. 2018;18:1055.
    PubMed     Abstract available

  97. LIU X, Cai H, Sheng W, Huang H, et al
    microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.
    BMC Cancer. 2018;18:1048.
    PubMed     Abstract available

  98. XIE JW, Lu J, Wang JB, Lin JX, et al
    Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    BMC Cancer. 2018;18:1021.
    PubMed     Abstract available

  99. YAPRAK G, Gemici C, Temizkan S, Ozdemir S, et al
    Osteoporosis development and vertebral fractures after abdominal irradiation in patients with gastric cancer.
    BMC Cancer. 2018;18:972.
    PubMed     Abstract available

  100. HE H, Li H, Su X, Li Z, et al
    Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02-01 multicenter randomized controlled clinical trial.
    BMC Cancer. 2018;18:944.
    PubMed     Abstract available

    September 2018
  101. CHEN M, Jiang B, He B, Tang M, et al
    Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
    BMC Cancer. 2018;18:923.
    PubMed     Abstract available

  102. SLAGTER AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, et al
    CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in res
    BMC Cancer. 2018;18:877.
    PubMed     Abstract available

  103. FENG F, Liu J, Wang F, Zheng G, et al
    Prognostic value of differentiation status in gastric cancer.
    BMC Cancer. 2018;18:865.
    PubMed     Abstract available

    August 2018
  104. LIU W, Fan Y, Shi Y, Lin Z, et al
    Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells.
    BMC Cancer. 2018;18:857.
    PubMed     Abstract available

  105. HUSSEIN UK, Park HS, Bae JS, Kim KM, et al
    Expression of oxidized protein tyrosine phosphatase and gammaH2AX predicts poor survival of gastric carcinoma patients.
    BMC Cancer. 2018;18:836.
    PubMed     Abstract available

  106. LI N, Wang X, Tang Y, Zhao D, et al
    A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer.
    BMC Cancer. 2018;18:803.
    PubMed     Abstract available

  107. HU D, Peng F, Lin X, Chen G, et al
    Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study.
    BMC Cancer. 2018;18:785.
    PubMed     Abstract available

    July 2018
  108. HWANG H, Lee KM, Son KL, Jung D, et al
    Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer.
    BMC Cancer. 2018;18:765.
    PubMed     Abstract available

  109. WANG Z, Li M, Xu Z, Jiang Y, et al
    Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clustering.
    BMC Cancer. 2018;18:706.
    PubMed     Abstract available

    June 2018
  110. LIU X, Zhang D, Lin E, Chen Y, et al
    Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
    BMC Cancer. 2018;18:699.
    PubMed     Abstract available

  111. WANG Y, Cheng X, Cui YH, Hou J, et al
    Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
    BMC Cancer. 2018;18:702.
    PubMed     Abstract available

  112. WANG Y, Chen Y, Li X, Hu W, et al
    Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
    BMC Cancer. 2018;18:691.
    PubMed     Abstract available

  113. ZHAO G, Jiang T, Liu Y, Huai G, et al
    Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    BMC Cancer. 2018;18:676.
    PubMed     Abstract available

  114. LIU X, Ma M, Huang H, Wang Y, et al
    Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.
    BMC Cancer. 2018;18:649.
    PubMed     Abstract available

  115. KUBO N, Yoshizawa J, Hanaoka T
    Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
    BMC Cancer. 2018;18:627.
    PubMed     Abstract available

    May 2018
  116. LIU Z, Zheng G, Liu J, Liu S, et al
    Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients.
    BMC Cancer. 2018;18:563.
    PubMed     Abstract available

  117. WANG G, Zhao J, Song Y, Zhang W, et al
    Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
    BMC Cancer. 2018;18:547.
    PubMed     Abstract available

  118. SCHNEIDER PM, Eshmuminov D, Rordorf T, Vetter D, et al
    (18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
    BMC Cancer. 2018;18:548.
    PubMed     Abstract available

  119. HSIEH YY, Tung SY, Pan HY, Yen CW, et al
    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
    BMC Cancer. 2018;18:508.
    PubMed     Abstract available

  120. HUANG Z, Liu Y, Yang C, Li X, et al
    Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
    BMC Cancer. 2018;18:515.
    PubMed     Abstract available

  121. HONG SA, Yoo SH, Lee HH, Sun S, et al
    Prognostic value of Dickkopf-1 and ss-catenin expression in advanced gastric cancer.
    BMC Cancer. 2018;18:506.
    PubMed     Abstract available

  122. KHAN S, Zhu LP, Zhang Y, Chen X, et al
    Laterally spreading tumour of the distal stomach: a case report.
    BMC Cancer. 2018;18:502.
    PubMed     Abstract available

    April 2018
  123. WANG T, Lu ZY, Tu XF, Zhang SH, et al
    Computerized tomography findings in calcified signet-ring gastric cancer receiving chemotherapy: a case report.
    BMC Cancer. 2018;18:474.
    PubMed     Abstract available

  124. LINK H, Angele M, Schuller M, Ganschow P, et al
    Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
    BMC Cancer. 2018;18:483.
    PubMed     Abstract available

  125. ZHANG C, Li Z, Xu L, Che X, et al
    CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    BMC Cancer. 2018;18:462.
    PubMed     Abstract available

  126. ITO S, Ohashi Y, Sasako M
    Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    BMC Cancer. 2018;18:449.
    PubMed     Abstract available

  127. BRENKMAN HJF, Gertsen EC, Vegt E, van Hillegersberg R, et al
    Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).
    BMC Cancer. 2018;18:450.
    PubMed     Abstract available

  128. SUN XJ, Shi JF, Guo LW, Huang HY, et al
    Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.
    BMC Cancer. 2018;18:435.
    PubMed     Abstract available

  129. LIU HN, Wu H, Tseng YJ, Chen YJ, et al
    Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.
    BMC Cancer. 2018;18:415.
    PubMed     Abstract available

  130. GIRARDI DM, de Lima MA, Pereira GCB, Negrao MV, et al
    Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2018;18:378.
    PubMed     Abstract available

    March 2018
  131. SUNDAR R, Rha SY, Yamaue H, Katsuda M, et al
    A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.
    BMC Cancer. 2018;18:332.
    PubMed     Abstract available

  132. ZHANG N, Chai D, Du H, Li K, et al
    Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
    BMC Cancer. 2018;18:344.
    PubMed     Abstract available

  133. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    PubMed     Abstract available

  134. MULLER V, Clemens M, Jassem J, Al-Sakaff N, et al
    Long-term trastuzumab (Herceptin(R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
    BMC Cancer. 2018;18:295.
    PubMed     Abstract available

  135. HIRAHARA N, Tajima Y, Fujii Y, Kaji S, et al
    Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    BMC Cancer. 2018;18:285.
    PubMed     Abstract available

    February 2018
  136. LEE YH, Lee JW, Jang HS
    Correction to: Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2018;18:232.
    PubMed     Abstract available

  137. JIAO XD, Ding C, Zang YS, Yu G, et al
    Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
    BMC Cancer. 2018;18:206.
    PubMed     Abstract available

  138. NAMIKAWA T, Maeda H, Kitagawa H, Oba K, et al
    Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
    BMC Cancer. 2018;18:186.
    PubMed     Abstract available

  139. AHN MJ, Lee K, Lee KH, Kim JW, et al
    Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.
    BMC Cancer. 2018;18:173.
    PubMed     Abstract available

  140. FENG F, Zheng G, Guo X, Liu Z, et al
    Impact of body mass index on surgical outcomes of gastric cancer.
    BMC Cancer. 2018;18:151.
    PubMed     Abstract available

  141. KIM SH, Yoo HS, Joo MK, Kim T, et al
    Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.
    BMC Cancer. 2018;18:150.
    PubMed     Abstract available

  142. MARIETTE C, Renaud F, Piessen G, Gele P, et al
    The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    BMC Cancer. 2018;18:139.
    PubMed     Abstract available

  143. BRAGA-NETO MB, Carneiro JG, de Castro Barbosa AM, Silva IS, et al
    Clinical characteristics of distal gastric cancer in young adults from Northeastern Brazil.
    BMC Cancer. 2018;18:131.
    PubMed     Abstract available

    January 2018
  144. MIAO ZF, Liu XY, Wang ZN, Zhao TT, et al
    Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
    BMC Cancer. 2018;18:118.
    PubMed     Abstract available

  145. MATSUMOTO H, Kawazoe A, Shimada K, Fukuoka S, et al
    A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
    BMC Cancer. 2018;18:120.
    PubMed     Abstract available

  146. NISHIBEPPU K, Komatsu S, Ichikawa D, Imamura T, et al
    Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    BMC Cancer. 2018;18:108.
    PubMed     Abstract available

  147. CAO QH, Liu F, Li CZ, Liu N, et al
    Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.
    BMC Cancer. 2018;18:94.
    PubMed     Abstract available

  148. MACALINDONG SS, Kim KH, Nam BH, Ryu KW, et al
    Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
    BMC Cancer. 2018;18:73.
    PubMed     Abstract available

  149. LI Z, Li Z, Zhang L, Liu Q, et al
    Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study.
    BMC Cancer. 2018;18:63.
    PubMed     Abstract available

  150. SAEKI H, Emi Y, Oki E, Tokunaga S, et al
    Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
    BMC Cancer. 2018;18:57.
    PubMed     Abstract available

  151. ZENG B, Shi W, Tan G
    MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    BMC Cancer. 2018;18:34.
    PubMed     Abstract available

    December 2017
  152. HUANG J, He Y, Mcleod HL, Xie Y, et al
    miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ beta-catenin/EMT signaling cascade in gastric cancer.
    BMC Cancer. 2017;17:886.
    PubMed     Abstract available

  153. LU Y, Xu Q, Zuo Y, Liu L, et al
    Isoprenaline/beta2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    BMC Cancer. 2017;17:875.
    PubMed     Abstract available

  154. KELLER S, Kneissl J, Grabher-Meier V, Heindl S, et al
    Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.
    BMC Cancer. 2017;17:845.
    PubMed     Abstract available

  155. CAO GD, Chen K, Chen B, Xiong MM, et al
    Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    BMC Cancer. 2017;17:841.
    PubMed     Abstract available

  156. KAWAMOTO Y, Komatsu Y, Yuki S, Sawada K, et al
    Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
    BMC Cancer. 2017;17:837.
    PubMed     Abstract available

    November 2017
  157. GHOSH S, Bankura B, Ghosh S, Saha ML, et al
    Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India.
    BMC Cancer. 2017;17:782.
    PubMed     Abstract available

  158. RYU BK, Lee MG, Kim NH, Lee KY, et al
    Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression.
    BMC Cancer. 2017;17:766.
    PubMed     Abstract available

  159. HAMASHIMA C, Narisawa R, Ogoshi K, Kato T, et al
    Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers.
    BMC Cancer. 2017;17:740.
    PubMed     Abstract available

  160. FENG F, Tian Y, Xu G, Liu Z, et al
    Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    BMC Cancer. 2017;17:737.
    PubMed     Abstract available

    October 2017
  161. GUAN P, Chen Z, Zhang L, Pan L, et al
    Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report.
    BMC Cancer. 2017;17:679.
    PubMed     Abstract available

  162. LEE HH, Lee SH, Song KY, Na SJ, et al
    Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    BMC Cancer. 2017;17:670.
    PubMed     Abstract available

  163. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Correction to: Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:669.

  164. LIU S, Zhang Y, Chen L, Guan W, et al
    Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers.
    BMC Cancer. 2017;17:665.
    PubMed     Abstract available

    September 2017
  165. REYNOLDS KL, Bedard PL, Lee SH, Lin CC, et al
    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
    BMC Cancer. 2017;17:646.
    PubMed     Abstract available

  166. YE J, Huang J, Xu J, Huang Q, et al
    ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    BMC Cancer. 2017;17:626.
    PubMed     Abstract available

    August 2017
  167. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    PubMed     Abstract available

  168. JI X, Bu ZD, Li ZY, Wu AW, et al
    Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients.
    BMC Cancer. 2017;17:558.
    PubMed     Abstract available

  169. LEE YH, Lee JW, Jang HS
    Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2017;17:541.
    PubMed     Abstract available

    July 2017
  170. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    PubMed     Abstract available

    June 2017
  171. YOSHIZAWA J, Kubo N, Ishizone S, Karasawa F, et al
    Curative resection by splenectomy for solitary splenic metastasis from early gastric cancer: a case report and literature review.
    BMC Cancer. 2017;17:436.
    PubMed     Abstract available

    May 2017
  172. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:384.
    PubMed     Abstract available

  173. CHANG YW, Oh CH, Kim JW, Lee JW, et al
    Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.
    BMC Cancer. 2017;17:388.
    PubMed     Abstract available

  174. YOSHIZAWA J, Ishizone S, Ikeyama M, Nakayama J, et al
    Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
    BMC Cancer. 2017;17:368.
    PubMed     Abstract available

  175. JI X, Yan Y, Bu ZD, Li ZY, et al
    The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.
    BMC Cancer. 2017;17:345.
    PubMed     Abstract available

    April 2017
  176. SAITO H, Fushida S, Miyashita T, Oyama K, et al
    Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
    BMC Cancer. 2017;17:294.
    PubMed     Abstract available

  177. SHIN HB, An JY, Lee SH, Choi YY, et al
    Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
    BMC Cancer. 2017;17:287.
    PubMed     Abstract available

  178. KIM GM, Kim SJ, Song SK, Kim HR, et al
    Prevalence and prognostic implications of psychological distress in patients with gastric cancer.
    BMC Cancer. 2017;17:283.
    PubMed     Abstract available

  179. WU Z, Zhao J, Gao P, Song Y, et al
    Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis.
    BMC Cancer. 2017;17:275.
    PubMed     Abstract available

  180. XING X, Cai W, Ma S, Wang Y, et al
    Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
    BMC Cancer. 2017;17:268.
    PubMed     Abstract available

    March 2017
  181. SHU P, Qin J, Shen K, Chen W, et al
    The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III.
    BMC Cancer. 2017;17:238.
    PubMed     Abstract available

  182. WANG H, Lu J, Tang J, Chen S, et al
    Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
    BMC Cancer. 2017;17:191.
    PubMed     Abstract available

  183. LIU X, Guo W, Zhang W, Yin J, et al
    A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
    BMC Cancer. 2017;17:188.
    PubMed     Abstract available

  184. LEE JW, Choi MH, Lee YJ, Ali B, et al
    Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.
    BMC Cancer. 2017;17:185.
    PubMed     Abstract available

  185. HAMASHIMA C, Sasazuki S, Inoue M, Tsugane S, et al
    Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    BMC Cancer. 2017;17:183.
    PubMed     Abstract available

    February 2017
  186. LUO Y, Chen J, Huang K, Lin Y, et al
    Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    BMC Cancer. 2017;17:154.
    PubMed     Abstract available

  187. CHEN Z, Liang W
    Myopericytoma occurrence in the liver and stomach space: imaging performance.
    BMC Cancer. 2017;17:143.
    PubMed     Abstract available

  188. KOMAKI K, Kusaba T, Tanaka M, Kado H, et al
    Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    BMC Cancer. 2017;17:144.
    PubMed     Abstract available

  189. LOZANO-POPE I, Sharma A, Matthias M, Doran KS, et al
    Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer.
    BMC Cancer. 2017;17:133.
    PubMed     Abstract available

  190. YU B, Chen X, Li J, Gu Q, et al
    microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
    BMC Cancer. 2017;17:109.
    PubMed     Abstract available

    January 2017
  191. HUR H, Ham IH, Lee D, Jin H, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    BMC Cancer. 2017;17:87.
    PubMed     Abstract available

  192. RAO SV, Solum G, Niederdorfer B, Norsett KG, et al
    Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.
    BMC Cancer. 2017;17:68.
    PubMed     Abstract available

  193. DIAO D, Cheng Y, Song Y, Zhang H, et al
    D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer.
    BMC Cancer. 2017;17:56.
    PubMed     Abstract available

  194. LEE NK, Lee JH, Ivan C, Ling H, et al
    MALAT1 promoted invasiveness of gastric adenocarcinoma.
    BMC Cancer. 2017;17:46.
    PubMed     Abstract available

  195. OKAZAKI M, Fushida S, Harada S, Tsukada T, et al
    Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    BMC Cancer. 2017;17:23.
    PubMed     Abstract available

  196. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    PubMed     Abstract available

    December 2016
  197. PU WY, Zhang R, Xiao L, Wu YY, et al
    Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.
    BMC Cancer. 2016;16:943.
    PubMed     Abstract available

  198. HOFHEINZ R, Clouth J, Borchardt-Wagner J, Wagner U, et al
    Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    BMC Cancer. 2016;16:937.
    PubMed     Abstract available

    November 2016
  199. SEO SH, Kim SE, Kang YK, Ryoo BY, et al
    Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
    BMC Cancer. 2016;16:900.
    PubMed     Abstract available

    October 2016
  200. FENG M, Yao G, Yu H, Qing Y, et al
    Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
    BMC Cancer. 2016;16:794.
    PubMed     Abstract available

  201. JI X, Fu T, Bu ZD, Zhang J, et al
    Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    BMC Cancer. 2016;16:765.
    PubMed     Abstract available

    January 2016
  202. KUPCINSKAITE-NOREIKIENE R, Ugenskiene R, Noreika A, Rudzianskas V, et al
    Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    BMC Cancer. 2016;16:40.
    PubMed     Abstract available

  203. ZOU K, Yang S, Zheng L, Yang C, et al
    Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
    BMC Cancer. 2016;16:737.
    PubMed     Abstract available

  204. PARK WC, Kim HR, Kang DB, Ryu JS, et al
    Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
    BMC Cancer. 2016;16:358.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.